Pharma Times

MARCH 30, 2022

Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures

137

137

pharmaphorum

MARCH 30, 2022

Data from a massive real-world study of asthma patients has suggested that overuse of inhalers is widespread and leading to an elevated risk of severe exacerbations. The results from the SABINA registry programme in more than a million people with the respiratory disease show that 40% of patients were over-using short-acting beta agonist (SABA) inhalers, which are used on demand to open up the airways.

108

108

Outsourcing Pharma

MARCH 31, 2022

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

99

99

NY Times

MARCH 29, 2022

People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies are also eligible.

Immunity 87

Immunity Immunization Vaccines 87

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

MARCH 31, 2022

In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication

116

116

pharmaphorum

MARCH 31, 2022

University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company Linus Health for an undisclosed sum. The merger brings together Kinesis’ gait analysis tools with Linus’ digital brain health monitoring technologies, designed to spot diseases like Alzheimer’s before over symptoms develop.

Hospitals 101

Hospitals 101

Outsourcing Pharma

MARCH 29, 2022

The agency's requested funding for FY 2023, nearly 34% higher than for FY 2022, calls for investments in public health modernization and pandemic preparation.

91

91

Pharma Times

MARCH 30, 2022

ProKnow was chosen to enable healthcare providers to benchmark treatment metrics against best practice and support clinical excellence

120

120

pharmaphorum

APRIL 1, 2022

With the new Health and Care Bill edging ever closer to receiving Royal Assent, life sciences companies in the UK are preparing to navigate the most significant piece of NHS legislation in a decade. The new bill, which is expected to come into force on 1st July, will see Clinical Commissioning Groups replaced with Integrated Care Systems (ICSs) as statutory bodies across England.

95

95

NY Times

MARCH 28, 2022

Jada Pinkett Smith’s hair loss condition played a major role in an incident at the Oscars. Here’s what we know about it.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

MARCH 29, 2022

A leader from the healthcare technology company discusses the conflictâs impact on the region and beyond and the need to better guard against interruptions.

91

91

Pharma Times

MARCH 28, 2022

Digital health boost as new website focuses on dry eye disease, which currently affects one in four people across the UK

117

117

pharmaphorum

MARCH 31, 2022

Leading tennis players train two to three hours a day to prepare for tournaments and have daily coaching input to make them game ready. It’s a gruelling regime but the rewards are obvious. Competing at the top level in pharma sales could be developed by following in the fast footsteps of Roger Federer and Rafael Nadal. Experts believe time spent practising delivery and messaging will reap dividends providing it is grooved into a sales force or medical science liaison (MSL) team’s schedule.

Communication 91

Communication Hospitals 91

NY Times

MARCH 30, 2022

Taking these seven steps now can lower your risk and minimize the disruption to your family’s life.

Immunity 105

Immunity Immunization Vaccines 105

Eye on FDA

MARCH 30, 2022

Tectonic pandemic plates are shifting respecting the COVID-19 pandemic. For weeks now we have been watching caseloads in the United States broadly fall. It feels as if we are indeed shifting gears. There are other moving parts that are in motion as well. It is a fundamental re-shifting of the landscape. And there are consequences. First, government funding supporting access to vaccination and treatment for COVID has run out and so far, is not replenished.

Vaccines 76

Vaccines 76

Pharma Times

APRIL 1, 2022

Study demonstrates ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer

112

112

pharmaphorum

MARCH 30, 2022

Roche has suffered a setback with its much-anticipated pairing of anti-TIGIT antibody tiragolumab and PD-L1 inhibitor Tecentriq in small cell lung cancer (SCLC), in a blow to its ambitions in combination cancer immunotherapy. The SKYSCRAPER-02 showed that the combination of the two drugs given on top of chemotherapy was unable to improve progression-free survival versus Tecentriq (atezolizumab) plus chemo in extensive-stage SCLC – a notoriously hard-to-treat form of lung cancer.

Chemotherapy 85

Chemotherapy Immunity Immunization 85

NY Times

MARCH 30, 2022

“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.

Hospitals 98

Hospitals 98

Drug Channels

MARCH 29, 2022

Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. Broadcast live on April 22, 2022 , from 12:00 p.m. to 1:30 p.m. ET This page describes the event and explains how to purchase a registration to participate in the event.

Specialty Pharmacies 72

Specialty Pharmacies 72

Pharma Times

APRIL 1, 2022

New technology could reduce finger pricking by 50% while also providing patients with continuous data about blood sugar levels

Diabetes 109

Diabetes 109

pharmaphorum

MARCH 29, 2022

With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race to secure access to the developed vaccines. In this article, Ben Hargreaves examines how wealth determined the winners and what is now underway to help lower-income countries gain access to the available vaccines. At the beginning of the pandemic, there were two principal issues facing producing an effective vaccine: how can one be quickly developed, and how can production meet global demand?

Vaccines 77

Vaccines Generic Medicine 77

NY Times

MARCH 30, 2022

With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.

59

59

Drug Channels

MARCH 28, 2022

Informa Connect’s Medicaid & Government Pricing Congress. Hybrid Event In-Person: May 23-25, 2022, Philadelphia, PA | Virtual: June 1-2, 2022 www.informaconnect.com/medicaid-government-pricing. Don’t miss the Medicaid & Government Pricing Congress , coming up May 23-25, 2022 (in-person in Philadelphia) and June 1-2, 2022 (virtually)! You'll be part of the important discussions surrounding the critical policy updates and approaches to effectively contract, report and comply with state and

Drug Pricing 66

Drug Pricing 66

Pharma Times

MARCH 28, 2022

Collaboration between Babylon Health and tech giant seeks to speed up historically slow patient access to data

116

116

pharmaphorum

MARCH 30, 2022

Amazon’s latest push into the healthcare arena is focusing on one of the top new trends in clinical research – the shift towards decentralised trials. Amazon Web Services has teamed up with Thread, a US technology company that has developed a decentralised clinical trials (DCT) platform based on artificial intelligence and machine learning, to enhance and scale up the technology.

Compounding 67

Compounding 67

Drug Patent Watch

APRIL 1, 2022

Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Sarepta Theraps drug AMONDYS 45 appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Drug Channels

MARCH 31, 2022

Ah, it’s finally spring in downtown Philadelphia, our home base. (Photographic evidence on your right.) Along with sunshine and fine weather, this vernal equinox has ushered in a crop of new and noteworthy stories: Health inequities in utilization management Insurers compute big white bagging savings The biosimilar boom accelerates The patient upside of manufacturers’ copay support Whoa.

Biosimilars 81

Biosimilars 81

Pharma Times

MARCH 29, 2022

Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval

110

110

pharmaphorum

MARCH 30, 2022

CureVac and GlaxoSmithKline’s first attempt to develop a COVID-19 vaccine was a salutary reminder of the pitfalls in drug development, as the mRNA shot crashed and burned in a clinical trial last year, but they aren’t giving up. The first participants have been dosed in a new, second generation version – dubbed CV2CoV – which uses a different mRNA backbone and will be a key test of CureVac’s new vaccine design approach.

Vaccines 62

Vaccines Immunity Immunization Drug Development 62

Drug Patent Watch

APRIL 1, 2022

Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharmacy Joe

MARCH 30, 2022

In this episode, I’ll discuss whether melatonin can prevent ICU delirium. Episode 700: Can melatonin prevent ICU delirium? Subscribe on iTunes , Android , or Stitcher Numerous medications have been studied in an attempt to find something that prevents the development of ICU delirium. Studies involving melatonin have produced mixed results, and a group of authors from Australia sought to determine via a high quality randomized controlled trial whether melatonin can prevent the development of ICU

Inpatient 52

Inpatient Hospitals 52

Pharma Times

MARCH 29, 2022

Charter for Change examines reasons for inequalities and sets out recommendations to improve diabetes care

Diabetes 107

Diabetes 107

pharmaphorum

APRIL 1, 2022

NICE has reversed its stance on UCB and Amgen’s severe osteoporosis therapy Evenity, saying out can be prescribed on the NHS for women with the disease in England and Wales who are at high risk of fractures. The move – which comes after an agreement by UCB to reduce the price of the drug – makes Evenity (romosozumab) the first novel therapy for the bone-wasting condition to be available to the NHS across the UK in more than a decade.

Documentation 57

Documentation 57

Drug Patent Watch

APRIL 1, 2022

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are eighteen patents protecting…. The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Mirror

MARCH 31, 2022

It all started in March 2020 and it is now Jan 2022. We still can’t declare the COVID pandemic as “finished”. How has the pandemic impacted the field marketing activity of Pharma companies? What should the industry do to prepare for what will definitely be a new world, post-COVID? There were many analysts who, even before the pandemic, were saying that the role of Medical Representatives will reduce.

52

52